YIH
BVS icon

Y-Intercept (HK)’s Bioventus BVS Stock Holding History

Y-Intercept (HK)’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-27,074
Closed -$179K – 1592
2025
Q2 		$179K Buy
+27,074
New +$192K ﹤0.01% 1480
2024
Q2 		– Sell
-26,664
Closed -$139K – 1424
2024
Q1 		$139K Buy
26,664
+10,626
+66% +$51.9K 0.01% 1222
2023
Q4 		$84.5K Buy
+16,038
New +$63.5K 0.01% 1122
2023
Q3 		– Sell
-35,337
Closed -$102K – 1094
2023
Q2 		$102K Buy
35,337
+3,688
+12% +$7.08K 0.01% 1093
2023
Q1 		$33.9K Buy
+31,649
New +$60.5K ﹤0.01% 1118

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
KLP
Kent Lake PR Anasco, Puerto Rico $198M AUM 5.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Y-Intercept (HK)'s BVS Position: Q3 2025 in Review

Y-Intercept (HK) sold out of Bioventus (BVS) in Q3 2025, closing a stake of 27,074 shares — an estimated $179K sold.

Y-Intercept (HK) first reported a position in BVS in Q1 2023 and held it in 5 quarters. The position peaked at $179K in Q2 2025. 135 funds tracked by Wall St. Rank hold BVS as of Q3 2025.

  • Y-Intercept (HK) reported no remaining Bioventus position as of Q3 2025 after selling out during the quarter.
  • Y-Intercept (HK) sold 27,074 Bioventus shares in Q3 2025, an estimated $179K.
  • Y-Intercept (HK) first reported a position in Bioventus in Q1 2023 and held it in 5 quarters.
  • Y-Intercept (HK)'s Bioventus position peaked at $179K in Q2 2025.
  • 135 funds tracked by Wall St. Rank held Bioventus as of Q3 2025.

Based on Y-Intercept (HK)'s 13F filing for Q3 2025, filed 31 Oct 2025.